Related Experiment Video
Updated: Jul 2, 2026

Native Polyacrylamide Gel Electrophoresis Immunoblot Analysis of Endogenous IRF5 Dimerization
Published on: October 6, 2019
IRF-4 functions as a tumor suppressor in early B-cell development
Jaime Acquaviva1, Xiaoren Chen, Ruibao Ren
1Rosenstiel Basic Medical Sciences Research Center and Department of Biology, Brandeis University, Waltham, MA 02454-9110, USA.
Interferon regulatory factor-4 (IRF-4) acts as a tumor suppressor in early B-cell development. Its deficiency accelerates BCR/ABL-induced leukemia, while its expression inhibits cancer progression.
Area of Science:
- Hematology
- Oncology
- Molecular Biology
Background:
- Interferon regulatory factor-4 (IRF-4) is a key transcription factor in hematopoietic development and immune regulation.
- IRF-4 has context-dependent roles in oncogenesis, acting as a proto-oncogene in multiple myeloma but downregulated in other malignancies.
- BCR/ABL oncogene drives acute B-lymphoblastic leukemia (B-ALL) and is targeted by imatinib therapy.
Purpose of the Study:
- To investigate the role of IRF-4 in BCR/ABL-induced B-ALL.
- To determine how IRF-4 expression is affected by imatinib treatment in BCR/ABL-transformed cells.
- To elucidate the functional impact of IRF-4 on B-lymphoid progenitor transformation and leukemia development.
Main Methods:
- Analysis of IRF-4 protein levels in BCR/ABL-transformed lymphoblastic cells treated with imatinib.
- In vitro studies using B-lymphoid progenitors to assess the effects of IRF-4 deficiency and forced expression on BCR/ABL transformation.
- In vivo studies in mice to evaluate the impact of IRF-4 on BCR/ABL-induced B-ALL progression.
- Investigation of IRF-4's mechanism of action, focusing on cell-cycle regulation.
Main Results:
- IRF-4 protein levels increased in BCR/ABL-transformed cells upon imatinib treatment.
- IRF-4 deficiency enhanced BCR/ABL transformation and accelerated B-ALL progression in mice.
- Forced expression of IRF-4 suppressed BCR/ABL transformation and B-ALL development in vitro and in vivo.
- IRF-4 inhibited BCR/ABL+ B lymphoblast growth by negatively regulating cell-cycle progression.
Conclusions:
- IRF-4 functions as a tumor suppressor in the context of early B-cell development and BCR/ABL-induced leukemia.
- IRF-4's role in lymphoid leukemogenesis by BCR/ABL involves the negative regulation of cell-cycle progression.
- Understanding the context-dependent functions of IRF-4 is crucial for developing targeted cancer therapies.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
